Professional Documents
Culture Documents
Hyponatremia - StatPearls - NCBI Bookshelf
Hyponatremia - StatPearls - NCBI Bookshelf
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Hyponatremia
Authors
Affiliations
1 University of Pittsburgh
2 Christus Santa Rosa Hospitals
Objectives:
Describe the pathophysiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and its
association with hyponatremia.
Outline the importance of enhancing care coordination among the interprofessional team to ensure proper
evaluation and management of hyponatremia.
Introduction
Hyponatremia is defined as a serum sodium concentration of less than 135 mEq/L but can vary to some extent
depending upon the set values of varied laboratories.[1] Hyponatremia is a common electrolyte abnormality caused by
an excess of total body water in comparison to that of the total body sodium content. Edelman approved of the fact
that serum sodium concentration does not depend on total body sodium but is determined by the ratio of total body
solutes (e.g., total body sodium and total body potassium) to total body water.[2] Hyponatremia represents an
imbalance in this ratio where total body water is more than total body solutes. Total body water (TBW) has two main
compartments, extracellular fluid (ECF) accounting for one-third and intracellular fluid (ICF), accounting for the
remaining two-thirds. Sodium is the major solute of ECF and potassium for ICF.
Etiology
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 1/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
The etiology of hyponatremia can be classified based upon the volume status of the extracellular fluid. As mentioned
earlier, sodium is the major solute of extracellular fluid (ECF). Based upon the volume of ECF, a patient can be
classified into hypovolemic, euvolemic, or hypervolemic.[3]
Physiological stimuli that cause vasopressin release in adjunct with increased fluid intake can cause hyponatremia.
Hypothyroidism and adrenal insufficiency may contribute to an increased release of vasopressin. Physiological stimuli
for vasopressin release include loss of intravascular volume (hypovolemic hyponatremia) and the loss of effective
intravascular volume (hypervolemic hyponatremia).
Causes of Hypovolemic Hyponatremia (TBW decreases more than a decrease in total body sodium) [4]
Diuretics
Salt-wasting nephropathies
Cerebral salt-wasting syndrome (urinary salt wasting, possibly caused by increased brain natriuretic peptide)
Mineralocorticoid deficiency
Causes of Hypervolemic Hyponatremia (TBW increases greater than an increase in total body sodium) [5]
Renal causes (acute renal failure, chronic renal failure, nephrotic syndrome)
Iatrogenic
Causes of Euvolemic Hyponatremia (TBW increase with stable total body sodium)
Nonosmotic, pathologic vasopressin release may occur in the setting of normal volume status, as with euvolemic
hyponatremia.
Addison's disease
Hypothyroidism
High fluid intake in conditions like primary polydipsia; or potomania, caused by a low intake of solutes with
relatively high fluid intake
Iatrogenic
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 2/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
Medications that stimulate vasopressin release or potentiate the effects of vasopressin such as selective
serotonin-reuptake inhibitors and other antidepressants morphine and other opioids
Medications that cause hyponatremia such as carbamazepine or its analogs, vincristine, nicotine, antipsychotics,
chlorpropamide, cyclophosphamide, nonsteroidal anti-inflammatory drugs
Epidemiology
Hyponatremia is the most common electrolyte disorder, with a prevalence of 20% to 35% among hospitalized
patients. The incidence of hyponatremia is high among critical patients in the intensive care unit (ICU) and also in
postoperative patients. This is more common in elderly patients due to multiple comorbidities, multiple medications,
and a lack of access to food and drinks.[9]
Pathophysiology
Thirst stimulation, antidiuretic hormone (ADH) secretion, and handling of filtered sodium by kidneys maintain serum
sodium and osmolality. Normal plasma osmolality is around 275 mOsm/kg to 290 mOsm/kg. To maintain normal
osmolality, water intake should be equal to water excretion. The imbalance of water intake and excretion causes
hyponatremia or hypernatremia. Water intake is regulated by the thirst mechanism where osmoreceptors in the
hypothalamus trigger thirst when body osmolality reaches 295 mOsm/kg. Water excretion is tightly regulated by
antidiuretic hormone (ADH), synthesized in the hypothalamus, and stored in the posterior pituitary gland. Changes in
tonicity lead to either enhancement or suppression of ADH secretion. Increased ADH secretion causes reabsorption of
water in the kidney, and suppression causes the opposite effect. Baroreceptors in the carotid sinus can also stimulate
ADH secretion, but it is less sensitive than the osmoreceptors. Baroreceptors trigger ADH secretion due to decreased
effective circulating volume, nausea, pain, stress, and drugs.[10]
Hyperglycemia
Mannitol
Nonconductive irrigant solutions: these solutions contain mannitol, glycine, or sorbitol, and are used in
urological and gynecological procedures such as transurethral resection of the prostate (TURP).[11]
Hypotonic hyponatremia represents an excess of free water. This excess free water can be caused by two mechanisms:
Increased free water intake: The patient drinks a large volume of free water (greater than 18 L/day or greater
than 750 mL/h) that overwhelms kidney capacity to excrete free water. Examples of this are psychogenic
polydipsia, marathon runners, water drinking competitions, and ecstasy.
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 3/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
Decreased free water excretion: Patients drink a normal volume of free water, but the kidneys cannot excrete
the water for some reason.
There are three mechanisms involved in the inability of kidneys to excrete water:
1. High ADH activity: Three different mechanisms can cause high ADH:
Decreased effective arterial blood volume (EABV): antidiuretic hormone (ADH) is released when there is a
reduction of 15% or more of the EABV. This occurs with hypovolemia (e.g., vomiting, diarrhea), decreased
cardiac output (e.g., heart failure), or vasodilation (e.g., cirrhosis).
SIADH: ADH is secreted autonomously. Four general causes of this are brain disorders, lung disorders, drugs
(e.g., SSRI), and miscellanea (e.g., nausea and pain).
Cortisol deficiency: Cortisol exerts an inhibitory effect on ADH release. When cortisol is decreased, ADH
is released in large amounts. Adrenal insufficiency is the cause of this mechanism.[12]
2. Low glomerular filtration rate (GFR): a low glomerular filtration rate would impair the kidney's ability to get rid of
water. Typical examples are acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease
(ESRD).
3. Low solute intake: Patients on a regular diet consume 600 mOsm to 900 mOsm of solute per day. Solutes are
defined as substances that are freely filtered by the glomeruli but have a relative or absolute difficulty in being
reabsorbed by the tubules in relationship to water. The main solutes are urea (which comes from the metabolism of
proteins) and electrolytes (e.g., salt). Carbohydrates do not contribute to solute load. In steady-state conditions, solute
intake is equal to urine solute load. Therefore, it is expected that these patients also excrete 600 mOsm to 900 mOsm
of solute in the urine. Urine volume, and hence water excretion, is dependent on the urine solute load. The more solute
one needs to excrete, the larger the urine volume one needs to produce. The less solute one needs to excrete, the
smaller the urine volume one needs to produce. Patients who eat a low amount of solute per day (e.g., 200
mOsm/day), on steady-state conditions, will also excrete a low amount of solute in the urine, and therefore they will
do it in a smaller volume of urine. This decreased urine volume will limit the capacity of the kidneys to excrete water.
Typical examples of this are beer potomania and the tea-and-toast diet.
This is a condition where inappropriate secretion of ADH despite normal or increased plasma volume causes impaired
water excretion by the kidney leading to hyponatremia. SIADH is a diagnosis of exclusion, as there is no single test to
confirm the diagnosis. Patients are hyponatremic and euvolemic.[14]
Ectopic production of ADH (most commonly small cell carcinoma of the lung),
HIV,
Treatment includes fluid restriction and the use of vasopressin 2 receptor inhibitors.[12][15][12][15][12]
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 4/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
Symptoms can range from anorexia, nausea and vomiting, fatigue, headache, and muscle cramps to altered mental
status, agitation, seizures, and even coma.[17]
Apart from symptoms, a detailed history taking to include a history of pulmonary and CNS disorders, all home
medications, and social history (increased beer intake or use of MDM or ecstasy) is very important.
Patients with neurological symptoms and signs need to be treated promptly to prevent permanent neurological
damage.[18]
Evaluation
The following steps may be performed while evaluating a patient with suspected hyponatremia[19]:
Urine osmolality less than 100 mOsm/kg indicates primary polydipsia or reset osmostat.
Urine osmolality greater than 100 mOsm/kg usually indicates a high ADH state, go to step 3.
Urine sodium less than 10 mmol/L indicates extrarenal loss of fluid (remote diuretic use and remote vomiting).
Urine sodium greater than 20 mmol/L suggests renal loss of urine (diuretics, vomiting, cortisol deficiency, and
salt wasting nephropathies).
Serum adrenocorticotropic hormone (ACTH)
Serum urea
Treatment / Management
Treatment of hyponatremia depends upon the degree of hyponatremia, duration of hyponatremia, the severity of
symptoms, and volume status.
Severely symptomatic hyponatremia: Administer 3% sodium chloride; 100 mL intravenous (IV) bolus (repeat
up to twice if symptoms persist).
Mild to moderately symptomatic hyponatremia: 3% Sodium chloride, slow infusion (use sodium deficit formula
to calculate the rate of infusion but recalculate rate with frequent sodium monitoring).
Hypervolemic hyponatremia: Treat underlying condition, restrict salt and fluids, and administer loop diuretics.
Drugs: Selective vasopressin 2 receptor antagonists are being used recently. They increase the excretion of water in
the kidneys without affecting sodium, thereby increase serum sodium levels. These medications are used in patients
with euvolemic and hypervolemic conditions (except liver failure) if the above measure does not help.[20][21]
The goal of correction: Correct sodium by no more than 10 mEq/L to 12 mEq/L in any 24 hour period.
Risk factors for osmotic demyelination syndrome (ODS): Hypokalemia, liver disease, malnutrition, alcoholism.
Limits of Correction
In the absence of false laboratory hyponatremia, pseudo hyponatremia, and lack of hypovolemic state, including
postural hypotension, the next step is to measure the urine sodium and osmolarity. In the low urinary sodium of less
than 100 mOsm/kg and absence of rapid water consumption, the potential for a high fluid, low protein diet, including
beer potomania, should be examined. In patients with severe hyponatremia of less than 120 mEq/L, the chronicity of
the hyponatremia should be considered. Accordingly, in severe, chronic hyponatremia, intravenous 3 percent saline at
a rate of 15 to 30 mL/hour should be initiated. In some patients, desmopressin (dDAVP) should also be administered
to prevent overly rapid correction.
Three percent saline can be safely infused via a peripheral vein, and so far, vascular thrombosis and extravasation
injuries have not been reported. However, some centers have policies against the peripheral infusion of hypertonic
saline. In these circumstances, central vein infusions or infusion of a lower concentration with higher infusion rates
are required. Tolvaptan is indicated in hyponatremia associated with high anti-diuretic hormone (ADH) activity.
Fluid restriction is adequate for patients who have normovolemic hypotonic hyponatremia. Some patients with the
syndrome of inappropriate antidiuretic hormone secretion (SIADH) who are malnourished may need a high protein
intake, which increases the solute load for renal excretion, resulting in more free water removal. Laboratory findings
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 6/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
in patients with SIADH reveal hyponatremia (plasma sodium level of less than 135 mEq/L) and low serum osmolality
(less than 280 mOsm/kg). Moreover, patients with SIADH have increased urinary sodium levels (greater than 20
mMol/L) and urine osmolality (generally above 100 mOsm/L).[22]
Differential Diagnosis
True hyponatremia is associated with hypo osmolality. Conditions causing hyperosmolar hyponatremia and iso-
osmolar hyponatremia (pseudo-hyponatremia) should be differentiated first.[23]
Hyperglycemia
Mannitol overdose
Hyperlipidemia
Hyperproteinemia
Gastroenteritis
Diuretic use
Liver failure
Psychogenic polydipsia
Renal causes
SIADH
Adrenal crisis
Hypothyroidism
Prognosis
Prognosis in patients with hyponatremia depends on the severity of hyponatremia and the underlying condition
causing it. Prognosis is poor in patients with severe hyponatremia, acute hyponatremia, and elderly patients.[24]
Complications
If left untreated or inadequately treated, patients with hyponatremia can develop rhabdomyolysis, altered mental
status, seizures, and even coma.
Rapid correction of chronic hyponatremia (greater than 10 mEq/L to 12 mEq/L of sodium in 24 hrs) can lead to
osmotic demyelination syndrome.
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 7/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
syndrome occurs in severely affected patients. These patients are awake but unable to move or can communicate with
the help of their eyes only.[26]
Consultations
It is imperative to consult a nephrologist in a patient with severe hyponatremia or a rapid decrease in sodium or
persistent hyponatremia.
Cardiology and gastroenterology consultation might be necessary for patients with congestive heart failure and
hepatic failure, respectively.
Common causes include diuretics, vomiting, diarrhea, congestive heart failure, renal, and liver disease.
Degree, duration of hyponatremia, along with the severity of symptoms, determine the management algorithm
and the rapidity to correct sodium.
Do not correct the hyponatremia by more than 10 mEq/L to 12 mEq/L in 24 hours except in patients with severe
symptoms and rapidly decreased sodium levels.
Too rapid correction of the sodium levels can lead to the osmotic demyelinating syndrome.
Review Questions
References
1. Overgaard-Steensen C. Initial approach to the hyponatremic patient. Acta Anaesthesiol Scand. 2011
Feb;55(2):139-48. [PubMed: 21029052]
2. Overgaard-Steensen C, Larsson A, Bluhme H, Tønnesen E, Frøkiaer J, Ring T. Edelman's equation is valid in
acute hyponatremia in a porcine model: plasma sodium concentration is determined by external balances of water
and cations. Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R120-9. [PubMed: 19864338]
3.
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 8/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
Hoorn EJ, Zietse R. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. J Am Soc Nephrol.
2017 May;28(5):1340-1349. [PMC free article: PMC5407738] [PubMed: 28174217]
4. Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ. Diagnosis,
evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013 Oct;126(10 Suppl
1):S1-42. [PubMed: 24074529]
5. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C,
Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E., Hyponatraemia Guideline
Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial
Transplant. 2014 Apr;29 Suppl 2:i1-i39. [PubMed: 24569496]
6. Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and
hypernatremia. Am Fam Physician. 2015 Mar 01;91(5):299-307. [PubMed: 25822386]
7. Braun MM, Mahowald M. Electrolytes: Sodium Disorders. FP Essent. 2017 Aug;459:11-20. [PubMed: 28806046]
8. Barstow C, Braun M. Electrolytes: Calcium Disorders. FP Essent. 2017 Aug;459:29-34. [PubMed: 28806048]
9. Burst V. Etiology and Epidemiology of Hyponatremia. Front Horm Res. 2019;52:24-35. [PubMed: 32097911]
10. Rondon-Berrios H, Agaba EI, Tzamaloukas AH. Hyponatremia: pathophysiology, classification, manifestations
and management. Int Urol Nephrol. 2014 Nov;46(11):2153-65. [PubMed: 25248629]
11. Darwish OM, Lutnick E, Dalimov Z, Waisanen KM, Wang D, Houjaij A, Jung I, Nader ND. Neuraxial vs
General Anesthesia: 30-Day Mortality Outcomes Following Transurethral Resection of Prostate. Urology. 2021
Nov;157:274-279. [PubMed: 34274392]
12. Peri A, Grohé C, Berardi R, Runkle I. SIADH: differential diagnosis and clinical management. Endocrine. 2017
Jan;55(1):311-319. [PubMed: 27025948]
13. Martin J, Burnier M, Lu H. [Approach to the syndrome of inappropriate antidiuretic hormone secretion
(SIADH)]. Rev Med Suisse. 2018 Nov 21;14(628):2116-2120. [PubMed: 30462399]
14. De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela
JA, López López R. SIADH-related hyponatremia in hospital day care units: clinical experience and
management with tolvaptan. Support Care Cancer. 2016 Jan;24(1):499-507. [PMC free article: PMC4669367]
[PubMed: 26431960]
15. Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A. Medication-induced
SIADH: distribution and characterization according to medication class. Br J Clin Pharmacol. 2017
Aug;83(8):1801-1807. [PMC free article: PMC5510077] [PubMed: 28168757]
16. Tazmini K, Ranhoff AH. Electrolyte outpatient clinic at a local hospital - experience from diagnostics, treatment
and follow-up. BMC Health Serv Res. 2020 Feb 28;20(1):154. [PMC free article: PMC7048094] [PubMed:
32111205]
17. Mohottige D, Lehrich RW, Greenberg A. Hypovolemic Hyponatremia. Front Horm Res. 2019;52:93-103.
[PubMed: 32097947]
18. Peri A. Morbidity and Mortality of Hyponatremia. Front Horm Res. 2019;52:36-48. [PubMed: 32097927]
19. Filippatos TD, Liamis G, Christopoulou F, Elisaf MS. Ten common pitfalls in the evaluation of patients with
hyponatremia. Eur J Intern Med. 2016 Apr;29:22-5. [PubMed: 26706473]
20. Rondon-Berrios H, Berl T. Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and
Management. Clin J Am Soc Nephrol. 2015 Dec 07;10(12):2268-78. [PMC free article: PMC4670756]
[PubMed: 26109207]
21. Di Mise A, Venneri M, Ranieri M, Centrone M, Pellegrini L, Tamma G, Valenti G. Lixivaptan, a New Generation
Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct
Cells. Int J Mol Sci. 2019 Dec 26;21(1) [PMC free article: PMC6981680] [PubMed: 31888044]
22. Krisanapan P, Vongsanim S, Pin-On P, Ruengorn C, Noppakun K. Efficacy of Furosemide, Oral Sodium
Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label
Randomized Controlled Study (The EFFUSE-FLUID Trial). Am J Kidney Dis. 2020 Aug;76(2):203-212.
[PubMed: 32199708]
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 9/10
3/12/23, 6:08 PM Hyponatremia - StatPearls - NCBI Bookshelf
23. Girot H, Déhais M, Fraissinet F, Wils J, Brunel V. Atypical Pseudohyponatremia. Clin Chem. 2018
Feb;64(2):414-415. [PubMed: 29378746]
24. C A, Badiger R. Epidemiology of Hyponatraemia Among Elderly Patients with Lower Respiratory Tract
Infection. J Assoc Physicians India. 2020 Jan;68(1):80. [PubMed: 31979779]
25. Sterns RH. Adverse Consequences of Overly-Rapid Correction of Hyponatremia. Front Horm Res. 2019;52:130-
142. [PubMed: 32097948]
26. Reijnders TDY, Janssen WMT, Niamut SML, Kramer AB. Role of Risk Factors in Developing Osmotic
Demyelination Syndrome During Correction of Hyponatremia: A Case Study. Cureus. 2020 Jan 02;12(1):e6547.
[PMC free article: PMC6996461] [PubMed: 32042522]
27. Golestaneh L, Neugarten J, Southern W, Kargoli F, Raff A. Improving the diagnostic workup of hyponatremia in
the setting of kidney disease: a continuing medical education (CME) initiative. Int Urol Nephrol. 2017
Mar;49(3):491-497. [PubMed: 28091865]
Copyright © 2022, StatPearls Publishing LLC.
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) (
http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used
commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
https://www.ncbi.nlm.nih.gov/books/NBK470386/?report=printable 10/10